Website intended for a NZ health professional readership
Reporting by Virginia McMillan and Martin Johnston
1. Nair N, Kvizhinadze G, Jones G, et al. Health gains, costs and cost-effectiveness of a population-based screening programme for abdominal aortic aneurysms. BJS 2019;106:1043–1054.
2. Jones G, Sandiford P, Hill GB, et al. Correcting for body surface area identifies the true prevalence of abdominal aortic aneurysm in screened women. Eur J Vasc Endovasc Surg 2019;57(2):221-228.
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
